SCHEMBL6256286

SCHEMBL6256286

CC(C)(C)NS(=O)(=O)c1ccccc1-c1ccc(NC(=O)C(CO)(CO)NC(=O)Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 2/20 0.54
FPR1 P21462 1/20 0.54
NAMPT P43490 2/20 0.45
ALOX5AP P20292 3/20 0.41
FEN1 P39748 3/20 0.41
IDH2 P48735 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
IDH1 O75874 2/20 0.39
F10 P00742 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 1/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6244553 0.87 F10 (0.51) NAMPTMEN1KMT2AF10
SCHEMBL6807899 0.77 FPR2 (0.50) FPR2FPR1ALOX5APFEN1MEN1
SCHEMBL6381183 0.76 USP30 (0.56) FPR2FPR1F10
SCHEMBL6375140 0.76 USP30 (0.56) FPR2FPR1F10
SCHEMBL7061589 0.76 ALDH1A1 (0.54) FPR2FPR1ALOX5APFEN1MEN1
SCHEMBL7364780 0.74 ALOX5AP (0.51) FPR2FPR1ALOX5APFEN1MEN1
SCHEMBL6749780 0.73 PTPN1 (0.53) FPR2FPR1ALOX5APFEN1F10
Cyclopentane SCHEMBL7093842 0.72 FPR2 (0.52) FPR2FPR1ALOX5APFEN1F10
SCHEMBL6752209 0.72 ALOX5AP (0.48) FPR2FPR1ALOX5APFEN1F10
SCHEMBL18964061 0.71 FPR2 (1.00) FPR2FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539686-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2005-06-15 EP disclosed
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. 2004-08-26 US disclosed
WO-2004024679-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC (US) 2004-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167131-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade TFPI, SERPINC1, F11 FPR2 1122/4885FPR1 582/4885NAMPT 1938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.